Prevention of lymphocele with Floseal in renal transplantation: A multicentre randomized controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-16009066

Enrollment

Unknown

Registered

2016-08-19

Start date

2016-09-01

Completion date

Unknown

Last updated

2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphocele post renal transplantation

Interventions

Two groups:FloSeal, Once intra-operation versus No treatment

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Male or female patients older than 18 years old, with end-stage renal failure fit for renal transplantation. Renal transplantation candidates in PWH, PMH or QMH.

Exclusion criteria

Exclusion criteria: Allergy or adverse reaction to FloSeal.

Design outcomes

Primary

Measure	Time frame
incidence of symptomatic lymphocele;	—

Secondary

Measure	Time frame
Complications and adverse events;Post-operative drain output;Post-operative hospital stay;	—

Countries

China

Contacts

Public ContactDr. YEE Chi Hang

Division of Urology, Department of Surgery, The Chinese University of Hong Kong

yeechihang@surgery.cuhk.edu.hk+852 35051663

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026